US 11786546
Compounds and methods for modulating GFAP
granted A61KA61K31/7115A61K31/712
Quick answer
US patent 11786546 (Compounds and methods for modulating GFAP) held by Ionis Pharmaceuticals, Inc. expires Mon Oct 12 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Ionis Pharmaceuticals, Inc.
- Grant date
- Tue Oct 17 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 12 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 42
- CPC classes
- A61K, A61K31/7115, A61K31/712, A61K31/7125, A61K9/0019